↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Ljungman P) "

Search: WFRF:(Ljungman P)

Result 11-20 of 738

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
11.	Spanjaart, AM, et al. (author) Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group 2021 In: Leukemia. - : Springer Science and Business Media LLC. - 1476-5551 .- 0887-6924. ; 35:12, s. 3585-3588 Journal article (peer-reviewed)
12.	Ariza-Heredia, EJ, et al. (author) Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant 2023 In: Open forum infectious diseases. - 2328-8957. ; 10:8, s. ofad386- Journal article (peer-reviewed)
13.	Averbuch, D, et al. (author) Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study 2023 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 58:5, s. 558-566 Journal article (peer-reviewed)
14.	Basak, GW, et al. (author) Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT 2015 In: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. - : Elsevier BV. - 1600-6143. ; 15:3, s. 705-714 Journal article (peer-reviewed)
15.	Bergh, J, et al. (author) Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study 2000 In: Lancet (London, England). - 0140-6736. ; 356:9239, s. 1384-1391 Journal article (peer-reviewed)
16.	Bergh, J, et al. (author) Tailored fluorouracil, epirubicin, and cyclophosphamide compared withmarrow-supported high-dose chemotherapy as adjuvant treatment forhigh-risk breast cancer: a randomised trial. Scandinavian Breast G 2000 In: Lancet. ; 356, s. 1384- Journal article (peer-reviewed)
17.	Bogdanovic, G, et al. (author) A high BK virus load in urine samples combined with graft-versus-host disease frequently precedes and may predict a risk for haemorrhagic cystitis in haematopoietic stem cell transplanted patients 2004 In: BONE MARROW TRANSPLANTATION. - 0268-3369. ; 33, s. S201-S201 Conference paper (other academic/artistic)
18.	Bogdanovic, G, et al. (author) Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation 2004 In: Journal of clinical microbiology. - 0095-1137. ; 42:11, s. 5394-5396 Journal article (peer-reviewed)
19.	Cesaro, S, et al. (author) Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT 2020 In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 55:1, s. 110-116 Journal article (peer-reviewed)
20.	Chalandon, Y., et al. (author) Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT 2010 In: Bone Marrow Transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 45:3, s. 558-564 Journal article (peer-reviewed)abstract We studied GVHD after donor lymphocyte infusion (DLI) in 328 patients with relapsed CML between 1991 and 2004. A total of 122 patients (38%) developed some form of GVHD. We analyzed GVHD by clinical presentation (acute or chronic GVHD) and onset time after the first DLI (early (<= 45 days) or late (>45 days)). There was a significant overlap between onset time and clinical presentation. Some form of GVHD occurred at a median of 104 days, acute GVHD at 45 days and chronic GVHD at 181 days after DLI. The clinical presentation was acute GVHD in 71 patients, of whom 31 subsequently developed chronic GVHD subsequently. De novo chronic GVHD was seen in 51 patients. OS for all patients was 69% (95% confidence interval (CI) 63-75) at 5 years, DLI-related mortality was 11% (95% CI 8-15) and disease-related mortality was 20% (95% CI 16-25). Risk factors for developing GVHD after DLI were T-cell dose at first DLI, the time interval from transplant to DLI and donor type. In time-dependent multivariate analysis, GVHD after DLI was associated with a risk of death of 2.3-fold compared with patients without GVHD. Clinical presentation as acute GVHD and early onset GVHD were associated with increased mortality.

Skapa referenser, mejla, bekava och länka

Permalink

Result 11-20 of 738

Refine your search

Type of publication: journal article (548); conference paper (189); book chapter (1)

Type of content: peer-reviewed (510); other academic/artistic (228)

Author/Editor: Ljungman, P (684); Ringden, O (143); Remberger, M. (89); Mattsson, J. (76); Winiarski, J (64); Aschan, J (61); show more...; Cordonnier, C (59); Einsele, H (54); de la Camara, R (51); Hagglund, H (50); Styczynski, J (49); Cesaro, S (46); Kroger, N (42); Mikulska, M (39); Maertens, J (38); Volin, L (38); Gahrton, G (36); Lonnqvist, B (36); Niederwieser, D (33); Socie, G (33); Bellander, T (32); Hassan, M (32); Bjorkstrand, B (32); Tridello, G (32); Gratwohl, A (31); Apperley, J (30); Pershagen, G (29); Sparrelid, E (29); Nagler, A (27); Yakoub-Agha, I (27); Passweg, J (26); Mohty, M (25); Finke, J. (23); Labopin, M (23); Stafoggia, M (23); Averbuch, D (23); Michallet, M (21); Engelhard, D (21); Martino, R (20); Lenhoff, S (20); Chevallier, P. (19); Barkholt, L (18); Le Blanc, K (18); van Biezen, A (18); Peters, A (17); Hassan, Z. (17); Nilsson, C (17); Uhlin, M. (17); Dalianis, T (17); Knelange, N (17); show less...

University: Karolinska Institutet (711); Uppsala University (53); University of Gothenburg (29); Linköping University (13); Lund University (13); Örebro University (7); show more...; Umeå University (6); Stockholm University (5); Karlstad University (4); Högskolan Dalarna (4); Red Cross University College (4); Sophiahemmet University College (2); Royal Institute of Technology (1); Mälardalen University (1); University of Borås (1); show less...

Language: English (736); Swedish (1); German (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (70); Natural sciences (1); Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view